Insider Selling: Addus HomeCare (NASDAQ:ADUS) EVP Sells 284 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Roberton James Stevenson sold 284 shares of the firm’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $29,922.24. Following the transaction, the executive vice president owned 14,030 shares of the company’s stock, valued at $1,478,200.80. The trade was a 1.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Roberton James Stevenson also recently made the following trade(s):

• On Tuesday, February 24th, Roberton James Stevenson sold 567 shares of Addus HomeCare stock. The stock was sold at an average price of $107.35, for a total transaction of $60,867.45.

Addus HomeCare Stock Down 3.3%

NASDAQ:ADUS traded down $3.58 on Thursday, reaching $104.02. 269,378 shares of the stock traded hands, compared to its average volume of 239,147. The company’s fifty day simple moving average is $109.57 and its 200 day simple moving average is $113.08. The company has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 1.26 and a beta of 0.91. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $124.43. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11.

Addus HomeCare News Roundup

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. TimesSquare Capital Management LLC increased its position in shares of Addus HomeCare by 6.2% during the 3rd quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock valued at $49,361,000 after purchasing an additional 24,301 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Addus HomeCare by 10.1% in the second quarter. Russell Investments Group Ltd. now owns 55,900 shares of the company’s stock worth $6,439,000 after buying an additional 5,110 shares during the last quarter. Public Sector Pension Investment Board grew its position in Addus HomeCare by 14.4% during the third quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock valued at $8,357,000 after buying an additional 8,893 shares during the period. Creative Planning increased its holdings in Addus HomeCare by 150.9% during the second quarter. Creative Planning now owns 7,024 shares of the company’s stock valued at $809,000 after buying an additional 4,224 shares during the last quarter. Finally, Tributary Capital Management LLC raised its position in Addus HomeCare by 114.1% in the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock worth $46,974,000 after acquiring an additional 212,192 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ADUS has been the subject of a number of research analyst reports. Stephens reduced their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday. Barclays dropped their price objective on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Finally, TD Cowen reiterated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $134.33.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.